2022 annual financial data
InMed Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was -1,265.95%.
Operating income was -13,791,756 CAD and net income was -18,600,117 CAD.
Operating cash flow was -15,583,758 CAD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,089,435 CAD
- Operating income
- -13,791,756 CAD
- Net income
- -18,600,117 CAD
- Operating cash flow
- -15,583,758 CAD